This protocol addresses the management of Barrett's esophagus (BE) in patients with confirmed low-grade dysplasia (LGD) — a histologically verified finding that significantly changes the clinical course and requires a structured, evidence-based management decision.
Current guidelines identify endoscopic eradication therapy (EET) as a central consideration in this population. The decision between proceeding with intervention or continued surveillance is nuanced — the full structured protocol defines the pathway and criteria in detail.
DOI: 10.1053/j.gastro.2025.09.012